BioCorRx Inc. (BICX)
OTCMKTS · Delayed Price · Currency is USD
0.4000
0.00 (0.00%)
Oct 24, 2025, 4:00 PM EDT
BioCorRx Market Cap
BioCorRx has a market cap or net worth of $8.06 million as of October 27, 2025. Its market cap has decreased by -42.33% in one year.
Market Cap
8.06M
Enterprise Value
10.51M
Revenue
313.14K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.40
Market Cap Chart
Since November 1, 2011, BioCorRx's market cap has increased from 2.26M to 8.06M, an increase of 256.29%. That is a compound annual growth rate of 9.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 8.06M | 61.96% |
| Dec 31, 2024 | 4.98M | -26.29% |
| Dec 29, 2023 | 6.75M | -9.64% |
| Dec 30, 2022 | 7.47M | -74.20% |
| Dec 31, 2021 | 28.98M | 462.57% |
| Dec 31, 2020 | 5.15M | -64.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 670.91M |
| Glass House Brands | 619.92M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 344.81M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 327.16M |
| American Oncology Network | 291.52M |